Phytoconstituents of Terminalia catappa linn fruits extract exhibit promising antidiabetic activities against α-amylase and α-glucosidase in vitro and in silico

Terminalia Catappa fruits are recognized for their use in diabetes treatment, yet the mechanism by which they inhibit diabetes-related enzymes remain largely undefined. This study aimed to elucidate the therapeutic potential and interactions of T. catappa fruit extract through in vitro and in silico...

Full description

Bibliographic Details

Published in:	Informatics in Medicine Unlocked
Main Authors:	Fitri Amelia, Hesty Parbuntari, Iryani, Ikhwan Resmala Sudji, Sherly Rahmayani, Andini Novita Ramadhani, Shilvira Ananda
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Subjects:	α-glucosidase α-amylase Terminalia catappa linn fruit Microwave-assisted extraction (MAE) Molecular docking
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352914824000650